Literature DB >> 22271478

Deep time: the long and the short of adjuvant endocrine therapy for breast cancer.

Harold J Burstein, Jennifer J Griggs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22271478     DOI： 10.1200/JCO.2011.40.1455

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

Review 1.  Metastasis dormancy in estrogen receptor-positive breast cancer.

Authors:  Xiang H-F Zhang; Mario Giuliano; Meghana V Trivedi; Rachel Schiff; C Kent Osborne
Journal:  Clin Cancer Res       Date:  2013-12-01       Impact factor: 12.531

2.  A gene signature for late distant metastasis in breast cancer identifies a potential mechanism of late recurrences.

Authors:  Lorenza Mittempergher; Mahasti Saghatchian; Denise M Wolf; Stefan Michiels; Sander Canisius; Philippe Dessen; Suzette Delaloge; Vladimir Lazar; Stephen C Benz; Thomas Tursz; René Bernards; Laura J van't Veer
Journal:  Mol Oncol       Date:  2013-07-17       Impact factor: 6.603

3.  The GALNT9, BNC1 and CCDC8 genes are frequently epigenetically dysregulated in breast tumours that metastasise to the brain.

Authors:  Rajendra P Pangeni; Prasanna Channathodiyil; David S Huen; Lawrence W Eagles; Balraj K Johal; Dawar Pasha; Natasa Hadjistephanou; Oliver Nevell; Claire L Davies; Ayobami I Adewumi; Hamida Khanom; Ikroop S Samra; Vanessa C Buzatto; Preethi Chandrasekaran; Thoraia Shinawi; Timothy P Dawson; Katherine M Ashton; Charles Davis; Andrew R Brodbelt; Michael D Jenkinson; Ivan Bièche; Farida Latif; John L Darling; Tracy J Warr; Mark R Morris
Journal:  Clin Epigenetics       Date:  2015-05-27       Impact factor: 6.551

4.  Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patients.

Authors:  Daniella Klebaner; Stephen Hamilton-Dutoit; Thomas Ahern; Anatasha Crawford; Thomas Jakobsen; Deirdre P Cronin-Fenton; Per Damkier; Emiel Janssen; Anders Kjaersgaard; Anne Gulbech Ording; Håvard Søiland; Henrik Toft Sørensen; Timothy L Lash; Ylva Hellberg
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

5.  Late recurrence of breast cancer is associated with pro-cancerous immune microenvironment in the primary tumor.

Authors:  Takashi Takeshita; Li Yan; Mariko Asaoka; Omar Rashid; Kazuaki Takabe
Journal:  Sci Rep       Date:  2019-11-15       Impact factor: 4.379

6.  Prediction of late disease recurrence and extended adjuvant letrozole benefit by the HOXB13/IL17BR biomarker.

Authors:  Dennis C Sgroi; Erin Carney; Elizabeth Zarrella; Lauren Steffel; Shemeica N Binns; Dianne M Finkelstein; Jackie Szymonifka; Atul K Bhan; Lois E Shepherd; Yi Zhang; Catherine A Schnabel; Mark G Erlander; James N Ingle; Peggy Porter; Hyman B Muss; Katherine I Pritchard; Dongsheng Tu; David L Rimm; Paul E Goss
Journal:  J Natl Cancer Inst       Date:  2013-06-28       Impact factor: 13.506
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.